Aandeel BIOPHARMX CORP
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Biopharmx Corp Nyse

Aandelen

US09072X1019

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals to Be Delisted From NYSE American
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers TMBR
  4. Koers
  5. Nieuws Biopharmx Corp
  6. Andere talen